.jpg)
1 hour ago
2
Article content
Five-year extension builds on a decade of groundbreaking discoveries in cancer, orthopaedics and behavioral health research, advancing the Mountain West as a hub for world-class medical research
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
Vail, Colorado, Jan. 28, 2026 (GLOBE NEWSWIRE) — Steadman Philippon Research Institute (SPRI) and Vail Health have renewed their longstanding partnership with a new five-year agreement advancing medical research and innovation.
Article content
Article content
Article content
The extension builds on a highly successful 10-year collaboration launched in 2015, which fueled major breakthroughs in regenerative medicine, including collaborative studies in cancer and behavioral health. The previous agreement enabled significant scientific growth and discovery for both SPRI and Vail Health during the past decade.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
“SPRI has experienced tremendous growth and our partnership with Vail Health has been critical to much of our success during the past 10 years,” said Marc J. Philippon, M.D., Chairman of SPRI and Managing Partner of The Steadman Clinic. “Together with Vail Health, we’ve not only advanced orthopaedic and cancer research but also contributed to global medical knowledge. Many of our shared research projects are ongoing. The next five years will allow us to deepen that impact and pursue new frontiers in regenerative medicine and longevity.”
Article content
“Vail Health greatly values our longstanding partnership with SPRI that, in conjunction with our orthopaedic partners, has solidified the Vail area as a world-renowned destination for research and orthopaedics,” said Will Cook, president and CEO of Vail Health. “Continuing this collaboration with SPRI and expanding it to new avenues of study is in perfect alignment with our mission of elevating health across our mountain communities. The research results that come out of SPRI are a true benefit to our community, and we are proud to support their efforts.”
Article content
Article content
The original partnership provided significant support for SPRI to establish vital laboratory infrastructure, launch its regenerative medicine program and provided seed funding for pilot studies and research programs. Several of these pilot studies went on to become multi-year clinical studies and trials funded by the National Institutes of Health (NIH) and Department of Defense (DoD), enrolling patients from across the Vail area. Since the original partnership between the organizations, clinicians and scientists have investigated innovative treatments for orthopaedic conditions, including the use of anti-fibrotic medications and senolytic supplements alongside biologic therapies and advanced surgical techniques.
Article content
The renewed partnership will include advancing two foundational collaborations already yielding significant breakthroughs—cancer and behavioral health research.
Article content
- Vail Health’s Shaw Cancer Center in Edwards, Colorado is applying SPRI’s anti-fibrotic orthopaedic research to breast cancer patients experiencing radiation-induced fibrosis. Early pilot studies show promising results, and continuing this work will remain a central priority, including the pursuit of federal grants and expanding to other cancer types.
English (US)